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In a recent meta-analysis migraine was associated with a two-fold increase in stroke risk. While the mechanism
driving this association is unknown, one intriguing hypothesis is that migraineurs are genetically predisposed to
developing ischemic stroke. Mutations in the ATP1A2 gene are implicated in familial hemiplegic migraine type II
and increase the severity of ischemic brain injury in animal models. To further explore these observations, we
assessed the association between ATP1A2 polymorphisms, migraine, and the risk of ischemic stroke in participants
of the Genetics of Early-Onset Stroke Study, a population-based case–control study of ischemic stroke among men
and women aged 15–49. Using responses to a headache symptoms questionnaire, subjects were classified as
having no migraine, or migraine with or without visual aura. Evaluating a total of 134 ATP1A2 polymorphisms
genotyped using a combination of Illumina platforms (Cardiovascular Gene-centric 50 K SNP Array and
HumanOmni1-Quad_v1-0_B Bead Chip), only one polymorphism (rs2070704) demonstrated a nominally significant
association with stroke in an age-, gender-, ethnicity-adjusted model (OR = 0.83, 95% CI = 0.71-0.98, p = 0.025) and in
a vascular risk factor model adjusting for age, gender, ethnicity, hypertension, diabetes, smoking, and myocardial
infarction (OR = 0.74, 95% CI = 0.63-0.89, p = 0.001). Ethnicity-stratified analyses demonstrated a significant
association for rs2070704 among African-Americans (OR = 0.68, 95% CI = 0.53-0.90, p = 0.005) but not Caucasians
(OR = 0.82, 95% CI = 0.64-1.04, p = 0.107). These associations were unchanged when migraine subtypes were
included as co-variates. We did not observe an association between ATP1A2 polymorphisms and migraine. While
our results do not demonstrate a strong relationship between ATP1A2 polymorphisms and migraine associated
stroke risk, the results are hypothesis generating and indicate that an association between ATP1A2 polymorphisms
and stroke risk may exist. Additional studies are required.
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Table 1 Demographic and clinical characteristics of cases/
controls
Cases (n = 830) Controls (n = 907) P
Age* 43 (39–47) 41 (36–44) <0.001
Female 354 (43%) 407 (45%) 0.421
Black 353 (43%) 354 (39%) 0.207
HTN 371 (45%) 181 (20%) <0.001
MI 62 (7.5%) 14 (1.5%) <0.001
DM 147 (18%) 55 (6%) <0.001
Smoking 348 (42%) 257 (28%) <0.001
OC 57 (16%) 34 (8%) <0.001
Migraine
MWA 226 (27%) 193 (21%) 0.005
MWoA 56 (7%) 73 (8%) 0.346
HTN, Hypertension MI, Myocardial Infarction DM, Diabetes Mellitus Type II OC,
Oral Contraceptive use. * Age is expressed as median (25th-75th percentile).
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Although the evidence supporting an etiologic relationship
between migraine and ischemic stroke risk is substantial
(Cole & Kittner 2010; Sacco et al. 2012; Sacco et al. 2008;
Sacco et al. 2006), the precise mechanism(s) driving this
relationship remains uncertain. Stroke, which typically
affects older individuals, can be targeted for prevention by
optimizing well-established standard vascular risk factors
such as hypertension, diabetes, and hypercholesterolemia,
among others. However, there exist young stroke popula-
tions (e.g. < 50 years of age) who have a paucity of estab-
lished stroke risk factors. One explanation for stroke in this
young population is the existence of non-standard risk
factors, including migraine headache (Cole & Kittner 2010).
Migraine is a multi-factorial neurological condition
characterized by debilitating, recurrent headaches which
often affect women and men in younger age groups.
Migraine pathogenesis is believed to involve both genetic
and environmental factors which ultimately lead to activa-
tion of the trigeminovascular system, inflammation, and
changes in cerebral blood flow (D’Andrea & Leon 2010).
Notably, there is growing evidence that migraine is an
independent risk factor for ischemic stroke (Etminan
et al. 2005; Lampl & Marecek 2006; MacClellan et al.
2007; Moskowitz & Kurth 2007; Pezzini 2010; Spector
et al. 2010; Tzourio et al. 1995; Carolei et al. 1996). In re-
cent meta-analyses; migraine, particularly those associated
with aura, significantly increased the risk of stroke by two-
fold (Etminan et al. 2005; Spector et al. 2010). Furthermore,
this association was most profound in women, persons
aged 45 and younger, and those taking oral contraceptives
(Etminan et al. 2005). While the mechanism(s) driving this
association is (are) unknown, one potential hypothesis is
that migraineurs are more susceptible to developing
ischemic stroke due to a shared genetic predisposition
to both conditions. Consistent with this hypothesis,
studies evaluating genetic polymorphisms in the vaso-
constrictor endothelin-1 gene (EDN1) were associated
with increased risk of stroke risk as well as migraine
(Etminan et al. 2005; MacClellan et al. 2007; MacClellan
et al. 2009; Tikka-Kleemola et al. 2009). While a number
of additional candidate genes have been postulated to
increase stroke risk via such shared mechanisms, at
this time the definitive genetic links between migraine
and stroke remain elusive.
Familial hemiplegic migraine (FHM) is a rare inherited
form of migraine that presents with asymmetric neuro-
logical deficits (Tavraz et al. 2008). Several gene mutations
have been implicated in the pathogenesis of FHM including
genetic mutations in ATP1A2, CACNA1A and SCN1A.
These genes encode for a neuronal and glial Na+/K+
ATPase; a voltage gated Ca2+, and; a Na+ channel respect-
ively. Interestingly, ATP1A2 gene mutations result in
degeneration of the amygdala and pyriform cortex(Ikeda et al. 2003). Furthermore, failure of the Na+/K+
ATPase is involved in ischemic brain injury and gluta-
matergic excitotoxicity (Stys 2004; Wang & Qin 2010).
Such observations suggest that the ATP1A2 gene may
influence stroke risk and that some migraineurs may be
particularly predisposed. To test this hypothesis we assessed
the association between ATP1A2 single nucleotide poly-
morphisms (SNPs), migraine, and the risk of ischemic
stroke in a previously collected biracial case–control sample
of young-onset ischemic stroke.
Results
Demographic and clinical characteristics of the
population
Characteristics of the 1737 GEOS study participants
(830 cases - 43% African-American and 907 controls - 39%
African-American) are summarized in Table 1. The popu-
lation included men (56%) and women (44%) aged 15–49
with a median age of 43 in the cases and 41 in the controls.
Cases were more likely than controls to report having
prevalent hypertension, diabetes, and myocardial infarction
and to being current smokers. Among women with stroke,
cases reported a greater prevalence of oral contraceptive
use. Additionally, cases reported more Migraine with Aura
(27%) as compared to controls (21%).
ATP1A2 SNPs association studies with stroke
Association analyses between thirteen ATP1A2 SNPs
(see Figure 1) on ITMAT-Broad-CARe array and stroke
were initially performed. The minor allele frequencies
compared between cases and controls as stratified by
ethnicity are listed in Table 2.
Of the thirteen SNPs examined, only rs2070704 was
associated with stroke. As demonstrated in Table 3, the G
allele confers protection against stroke in the minimally
Figure 1 A. The ATP1A2 gene is located on chromosome 1 and contains 23 exons. B. Denotes the location and rs numbers of the
thirteen ATP1A2 SNPs genotyped as per the fixed content of the Illumina Cardiovascular Gene-centric 50 K SNP Array (ITMAT-Broad-CARe array)
(Keating et al. 2008).
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stronger protective effect in the risk factor fully adjusted
model (OR 0.74, 95% CI 0.6-0.9, p < 0.001). Stratified
analyses by ethnicity (including age, gender, hyperten-
sion, diabetes, myocardial infarction, smoking, and oral
contraceptive use as covariates) demonstrated an associ-
ation in the African-American population (OR 0.68, 95%
CI 0.5-0.9, p = 0.005), but not the Caucasian population
(OR 0.82, 95% CI 0.6-1.0, p = 0.107). Gender stratified
analyses demonstrated the association to be strongest
among African-American males (OR 0.55, 95% CI 0.4-0.8,
p = 0.002). Correcting for multiple comparisons including




ATP1A2 SNP* Position Black White Black White
rs11800782_A/G 160081369 0.014 0.037 0.004 0.053
rs4656879_C/T 160083012 0.298 0.140 0.322 0.149
rs11265328_A/G 160083544 0.025 0.099 0.025 0.106
rs3761685_C/T 160084643 0.024 0.128 0.027 0.125
rs1016732_A/G 160086968 0.113 0.173 0.093 0.179
rs2854248_A/G 160093927 0.459 0.359 0.477 0.359
rs1023421_A/G 160094644 0.492 0.382 0.448 0.377
rs9660705_C/T 160096810 0.065 0.000 0.063 0.000
rs6686067 _C/T 160102060 0.075 0.138 0.065 0.153
rs10797059_A/G 160102256 0.234 0.138 0.264 0.153
rs10494336_A/G 160107588 0.169 0.098 0.164 0.114
rs12410866 _C/T 160108803 0.025 0.115 0.023 0.130
rs2070704_A/G 160112138 0.228 0.195 0.287 0.205
* minor allele bolded.significant; our results for the entire population (p < 0.001)
remain nominally significant, however our results for the
African-American population (p = 0.005) do not.
Implementing the same regression models we then
evaluated the ATP1A2 GWAS data on these same study
subjects. As described in the Methods section, this larger
data set included 130 SNPs in the ATP1A2 gene, 9 of
which overlapped with the ITMAT-Broad-CARe array
data. As consistent with our ITMAT-Broad-CARe array
data, rs2070704 demonstrated an association. This was
the only SNP of the 130 SNPs evaluated that demon-
strated an association. Ethnicity stratified analyses evalu-
ating ischemic stroke risk associated with rs2070704
likewise demonstrated a significant association among
African-Americans (N = 733, MAF = 0.29, OR = 0.66, p =
0.0009) but not among European-Americans (N = 946,
MAF = 0.20, OR = 0.91, p = 0.40). Correcting for multiple
comparisons including all 134 SNPs evaluated, and as-
suming a p-value = 0.0004 (0.05/134) as significant, none
of our results remain significant.
Analyses of rs2070704 by stroke subtype in the combined
population only demonstrated an association among
strokes of undetermined etiology (OR 0.76, p = 0.009). Eth-
nicity stratified analyses demonstrated no subtype specific
associations among Caucasians. Among African-Americans
the protective effect of rs2070704 was greatest in the
large-artery atherosclerotic subtype (OR = 0.18, p = 0.002)
as compared to cardio-embolic (OR = 0.61, p = 0.029), small
vessel (OR = 0.71, p = 0.130) and strokes of undetermined
etiology (OR = 0.71, p = 0.030).
Migraine-stratified Analyses between rs2070704 SNP and
stroke
Utilizing the fully adjusted model we added migraine
status as a co-variate. The prediction for this analysis
Table 3 Effect of SNP rs2070704 on Ischemic Stroke Risk
Minimally adjusted model† Full model‡
Subjects Cases/controls MAF (G allele) cases/controls OR (95%CI) P OR (95%CI) P
Entire Population 829/899* 0.203/0.238 0.83 (0.7-0.9) 0.025 0.74(0.6-0.9) 0.001
Stratified
Blacks 355/351 0.225/0.288 0.71 (0.5-0.9) 0.007 0.68 (0.5-0.9) 0.005
Black Female 157/160 0.229/0.259 0.88 (0.6-1.3) 0.490 0.83 (0.6-1.2) 0.311
Black Male 198/191 0.215/0.312 0.58 (0.4-0.8) 0.002 0.55 (0.4-0.8) 0.002
Whites 431/500 0.188/0.205 0.93 (0.7-1.2) 0.499 0.82 (0.6-1.0) 0.107
White Female 165/215 0.210/0.209 1.03 (0.7-1.5) 0.867 0.88 (0.6-1.3) 0.530
White Male 266/285 0.174/0.202 0.85 (0.6-1.2) 0.291 0.80 (0.6-1.0) 0.093
†: Age, Gender, Race.
‡: Age, Gender, HTN, DM, MI, Smoking, Oral Contraceptive use, Race.
* Of the 830 cases and 907 controls, 3 cases and 6 controls failed genotyping at rs2070704.
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the rs2070704 SNP and stroke, adding migraine as a co-
variate should eliminate this association. However, when
migraine was included in the model, the association be-
tween rs2070704 and stroke (OR 0.75, 95% CI 0.6-0.89,
p = 0.0009; G-allele case/control: 0.221/0.260) remained
essentially unchanged. We then performed a restricted
analysis adding either migraine without aura or migraine
with aura as a co-variate. Again, there was no change in
the association; migraine without aura (OR 0.71, 95% CI
0.6-0.88, p = 0.0012) and migraine with aura (OR 0.76,
95% CI 0.6-0.9, p = 0.0024), indicating that migraine
status does not mediate the relationship between this
SNP and stroke risk.
Lastly, the association between ATP1A2 SNPs and
migraine status was tested using a fully adjusted logistic
regression model accounting for the same risk factors.
We did not observe an association between any ATP1A2
polymorphisms and migraine as defined by this study.
Discussion
Our analyses of the ATP1A2 gene demonstrated one
polymorphism that was nominally associated with ischemic
stroke; however this association did not persist with correc-
tion for multiple testing, nor was this association mediated
by migraine status. Our study was motivated by the fact
that prior studies have shown that the ATP1A2 gene is
implicated in rare forms of migraine (familial hemiplegic
migraine type II) which has features typical of migraine
with aura in addition to features consistent with transient
brain ischemia (Hansen et al. 2011; Mourand et al. 2012;
Eikermann-Haerter et al. 2012).
ATP1A2 encodes for the α2 subunit of Na
+/K+
ATPases (Pietrobon 2007). Figure 2 highlights several
potential mechanisms by which dysfunction of Na+/K+
ATPases could modify stroke risk. Glial Na+/K+ ATPases
are responsible for generating and maintaining ionic
electrochemical gradients across plasma membranes(Danbolt 2001). Data from experimental animal models
suggest that Na+/K+ ATPase dysfunction can dissipate
both Na+ and K+ gradients increasing the potential for
neuronal excitoxicity. Dissipation of the Na+ gradient
limits the effectiveness of Na+/Ca2+ transporters resulting
in excess accumulation of intracellular Ca2+. Similarly, dissi-
pation of the K+ gradient impairs K+ channel-mediated
membrane repolarization (Luo et al. 2004; Matsuda
et al. 2001). At excitatory glutamatergic synapses,
glutamate re-uptake is coupled to Na+ transport. Therefore,
decreases in Na+/K+ ATPase function raise glutamate
concentration at the synaptic cleft inducing glutamate-
mediated excitotoxicity and cell death (Rose et al. 2009).
Interestingly, in animal models of ischemic stroke,
decreases in Na+/K+ ATPase function and expression ap-
pear to play a significant role in neuro-degeneration during
cerebral infarction (Martin et al. 1994; Park & Jung 2010;
Sheldon & Robinson 2007). Prior genetic studies demon-
strate an association between the MTHFR C677T poly-
morphism and stroke that appear to be related to increased
homocysteine concentration (Casas et al. 2005), which in
animal models is linked to decreased Na+/K+ ATPase
function (Machado et al. 2011; Streck et al. 2002). As such,
these data provide evidence that there may be a common
pathway between the protein product of previously identi-
fied stroke-related genes and the ATP1A2 gene. These data
also allude to a potential combinatorial effect of multiple
genes which could play an intricate inter-related role in
stroke pathogenesis (Figure 2).
The presence of migraine has been shown to significantly
increase the risk of ischemic stroke (Cole & Kittner 2010;
Etminan et al. 2005; Lampl & Marecek 2006; MacClellan
et al. 2007; Hansen et al. 2011; Eikermann-Haerter
et al. 2012). This association is thought to be in part
related to a common genetic susceptibility; however, there
are few studies linking migraine-related genes with stroke
risk. One example is endothelin, a potent vasoconstrictor,
which has been shown to be increased in migraineurs in
Figure 2 Image demonstrating potential mechanisms relating how altered Na+/K+ ATPase (as coded by ATP1A2) function could be related
to stroke risk. Decreased Na+/K+ ATPase activity leads to: altered ionic (Na+, K+) gradients resulting in excess intracellular Ca2+ (Danbolt 2001);
impaired K+ channel-mediated membrane repolarization (Luo et al. 2004; Matsuda et al. 2001), and; elevated glutamate concentrations at the synaptic
cleft (Rose et al. 2009). Elevated homocysteine has been shown to decrease Na+/K+ ATPase function (Machado et al. 2011; Streck et al. 2002).
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recent case–control study demonstrated that poly-
morphisms in the Endothelin 1 gene increase stroke risk
(MacClellan et al. 2009), and in animal models of middle
cerebral artery occlusion, over-expression of endothelin
produced increased brain edema and ischemic brain
injury (Lo et al. 2005).
We used the strategy of studying the early-onset form
of ischemic stroke to identify genetic variants associated
with this complex disease for two reasons. First, the
early-onset form is thought to have a reduced cumulative
burden of standard risk factors, although they were highly
prevalent in our early-onset population as demonstrated in
Table 1. Second, genetic components are thought to have a
greater contribution to disease risk in this population
(MacClellan et al. 2006). While it is possible that genetic
variants associated with early-onset stroke may have little
relevance to late-onset stroke, it is also possible that study-
ing the early-onset form of diseases may reveal important
insights about stroke pathogenesis, potentially implicating
genes and pathways relevant to late-onset disease even
though the etiologic variants may differ.
There are several limitations to our study. The absence
of robust associations may be due to the limited sample
sizes (as stratified by gender, ethnicity, migraine status,
stroke subtype) which provided insufficient power to
detect causal variants with small effect sizes (e.g. less than
80% power to detect genetic risk effect less than 1.23).
Alternatively, one can argue that the early-onset form of
ischemic stroke may be more likely to be caused by rare
variants with larger effects (and higher penetrance).
Such rare variants are generally not well covered oncurrently available genotyping platforms and, thus, would
be difficult to detect using the common variants as
provided by GWAS data. Additionally, in our study popu-
lation, a greater percentage of subjects had migraine with
aura compared to migraine without aura which differs
from prior epidemiological studies (D’Andrea et al. 2011).
Of note, our headache questionnaire was not validated for
migraine, and the migraine criteria implemented for this
study were slightly different than those of the International
Headache Society (IHS). Both criteria use 5 attacks for
migraine without aura and 2 attacks for migraine with aura;
accompanied by nausea, vomiting, sensitivity to light and/
or sound. The migraine with aura group also reported the
presence of photopsia, fortification spectra or scotoma with
the headache. However, IHS criteria include a temporal
relationship between headache onset and aura, non-visual
aura and duration of headache. Despite these differences,
but similar to prior studies (MacClellan et al. 2007), there
was a greater percentage of migraineurs with aura in cases
as compared with controls. Lastly, our study may be
subject to recall bias, particularly among the case
subjects, who may have responded to the questionnaire
including headache symptoms, as far out as 3 years
following their stroke.
Conclusions
Our data indicate that common variants in the ATP1A2
gene do not play a large role in early-onset ischemic
stroke risk or migraine headache. While we did identify
one ATP1A2 polymorphism, rs2070704, that may play a
role in early-onset stroke pathogenesis, particularly
among African-Americans, migraine did not mediate
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confirm our findings in early-onset stroke and to
explore the relationship between ATP1A2 and older-
onset stroke.
Methods
Study population and design
Data from the retrospective case–control Genetics of
Early-Onset Stroke (GEOS) Study was used to determine
if SNPs in the ATP1A2 gene confer susceptibility to
stroke and if this susceptibility is mediated by migraine.
Subjects included 830 cases of first ever ischemic stroke
and 907 age, ethnicity and gender-matched controls that
were free of ischemic stroke. Study recruitment and data
collection occurred in three waves with the initial
recruitment for females occurring between 1992 and
1996, and again between 2001 and 2003. Male subjects
were recruited between 2003 and 2007. In all three
waves, cases were hospitalized with a first cerebral
infarction identified by discharge surveillance from one
of 59 hospitals in the greater Baltimore-Washington area
and direct referral from regional neurologists. The
methods for discharge surveillance, chart abstraction,
case adjudication, and assignment of probable and possible
underlying causes have been previously described elsewhere
(MacClellan et al. 2007; MacClellan et al. 2009; MacClellan
et al. 2006). Control subjects were subjects with no history
of stroke identified by random-digit dialing and were
matched to cases by age (within ten years) and geographic
region of residence. The first wave of female recruitment
included cases ages 15–44 years recruited within one year
of stroke and was designed with a 1:2 case to control ratio.
The second wave of female recruitment and the sole wave
of male recruitment included cases ages 15–49 recruited
within three years of stroke and designed with a 1:1 case to
control ratio. For all study periods, additional cases were
recruited after completion of control recruitment.
All study subjects signed Institutional Review Board
approved written informed consent forms. Subjects were
excluded from the study if they had genetic or other
known causes for their stroke that would impair
detection of new genetic associations. These conditions
included: sickle cell disease, thalassemia disease, central
nervous system vasculitis by angiogram and clinical
criteria, endocarditis, neurosyphillis, mechanical heart
valve, post-radiation arteriopathy, and cocaine use within
48 hours of stroke. Data on historical risk factors among
both cases and controls was collected by standardized
interview. Using responses to a headache symptoms
questionnaire, all subjects were classified as having no
migraine, or migraine with or without visual aura.
Subjects were classified as having migraine with visual aura
if they: (1) reported ever seeing spots, lines, or flashing
lights around the time of their probable migraine; or (2) ifthey reported ever experiencing loss of vision and also
reported a frequency of probable migraine with visual aura
of at least twice per year. Subjects were identified as having
probable migraine without visual aura if they reported no
history of visual aura and reported nausea, vomiting, or
sensitivity to light during a probable migraine and probable
migraine frequency of at least 5 times per year. Traditional
stroke risk factors and other study variables, including age,
ethnicity, history of hypertension, diabetes, myocardial
infarction (MI), and current smoking status (defined as use
within one month prior to event for cases and a compar-
able reference time for controls), were also collected during
a standardized interview. The abstracted hospital records
of cases were reviewed and adjudicated for ischemic stroke
subtype by a pair of vascular neurologists as previously
described (MacClellan et al. 2007) with disagreements
resolved by a third neurologist. The ischemic stroke
subtype classification system retains information on all
probable and possible causes, and is reducible to the more
widely used TOAST system (Adams et al. 1993) that
assigns each case to a single category. As previously
described, genomic DNA was isolated from a variety of
sample types, including cell line, whole blood, mouth wash,
and buccal swab among all case and controls subjects
(Hamedani et al. 2011).
Single nucleotide polymorphism selection
As demonstrated in Figure 1, the ATP1A2 gene is located
on chromosome 1q21-23, is 27.8 kb in size, and contains
23 exons (Genomic coordinates (GRCh37): 1:160,085,519 -
160,113,380). Our initial analyses included the 13 ATP1A2
SNPs distributed throughout the gene (denoted in Figure 1)
that were available from the fixed content on the Illumina
Cardiovascular Gene-centric 50 K SNP Array (ITMAT-
Broad-CARe array).(Keating et al. 2008) This fixed content
array includes 49,094 SNPs from ~2,000 loci and had been
previously implemented on our 830 case and 907 control
subjects. Genotyping was performed at the Institute for
Translational Medicine and Therapeutics (ITMAT),
University of Pennsylvania.
Shortly after completing our analyses, additional
ATP1A2 genotype data became available on these same
study subjects as provided by a genome-wide scan
(Cheng et al. 2011) implementing the Illumina Huma-
nOmni1-Quad_v1-0_B Bead Chip. These data provided
more extensive coverage of ATP1A2, including 130
SNPs, of which 9 SNPs overlapped between the two
fixed-content Illumina arrays. Comparing genotype calls
between the two arrays demonstrated >99% concordance
among the 9 overlapping SNPs. Inclusive of both
platforms, a total of 134 different SNPs were evaluated;
SNPs were required to have a minor allele frequency
greater than 5% in at least one of the two ethnicities
(i.e. Caucasians and/or African-Americans).
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Demographic and risk factor data between cases and
controls were compared with either a t-test or Χ2 test
using Sigma Plot v11.0 software. For primary analyses,
the entire population and then an ethnicity-stratified,
minimally adjusted additive logistic regression model
was used taking into account age and gender to test the
association between each SNP and stroke (CC = SNP +
age + gender where CC is case/control status). Each SNP
was then also evaluated utilizing a fully adjusted model
that included vascular risk factors; hypertension, prior
myocardial infarction, diabetes, oral contraceptive use,
and smoking. Analyses stratified by stroke subtype
(small vessel - lacunar; large vessel - atherosclerotic; cardi-
oembolic; stroke of unknown etiology - cryptogenic) were
performed including age, ethnicity, and gender as
covariates. SNPs demonstrating an association with stroke
were then further analyzed incorporating a variable for the
presence or absence of migraine, as well as the presence
or absence of migraine with aura. A fully adjusted model
was also used to test the association between ATP1A2
polymorphisms and migraine irrespective of the presence
or absence of stroke. All logistic regression analyses were
performed using SAS v9.2 software. Odds Ratios (OR) are
listed for minor alleles and a p < 0.05 was considered
nominally significant. Multiple comparisons were assessed
using a Bonferroni correction among the initial 13 SNPs
and then among the larger panel of 134 SNPs. Power
calculations (using CaTS Power Calculator @ http://www.
sph.umich.edu/csg/abecasis/cats/) indicated that our sam-
ple size of 830 cases and 907 controls provided 80% power
to detect ORs ranging 1.23–1.49 for allele frequencies
ranging 5–50% at an α = 0.05.
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